Inventory and Share Market Information, Financial system and Finance Information, Sensex, Nifty, International Market, NSE, BSE Dwell IPO Information

Zydus Lifesciences will get USFDA nod for generic drug to stop chest ache in coronary heart sufferers

The approval by the US Meals and Drug Administration (USFDA) is to fabricate and market Isosorbide Mononitrate Prolonged-Launch, of strengths 30 mg, 60 mg, and 120 mg, Zydus Lifesciences mentioned in a regulatory submitting.